Direct renin inhibition exerts an anti-hypertrophic effect associated with improved mitochondrial function in post-infarction heart failure in diabetic rats
- PMID: 22613984
- PMCID: PMC3980674
- DOI: 10.1159/000178526
Direct renin inhibition exerts an anti-hypertrophic effect associated with improved mitochondrial function in post-infarction heart failure in diabetic rats
Abstract
Background: In addition to hypertension control, direct renin inhibition has been shown to exert direct beneficial effects on the heart in post-infarction cardiac remodeling. This study elucidates the possible contribution of mitochondria to the anti-hypertrophic effects of the direct renin inhibitor aliskiren in post-infarction heart failure complicated with diabetes in rats.
Methods: Diabetes was induced in male Sprague-Dawley rats by a single injection of streptozotocin (IP, 65 mg/kg body weight). After 7 days, the animals were randomly assigned to 4 groups: sham, heart failure, sham+aliskiren, and heart failure+aliskiren. Post-infarction HF was induced by coronary artery ligation for 4 weeks.
Results: showed that heart failure reduced ejection fraction and cardiac output by 41% (P<0.01) and 42% (P<0.05), respectively, compared to sham-operated hearts. Cardiac dysfunction was associated with suppressed state 3 respiration rates and respiratory control index in mitochondria, and increased mitochondrial permeability transition pore (PTP) opening. In addition, heart failure reduced expression of the major mitochondrial sirtuin, SIRT3 and increased acetylation of cyclophilin D, a regulatory component of the PTP. Aliskiren significantly improved cardiac function and abrogated mitochondrial perturbations.
Conclusion: Our results demonstrate that aliskiren attenuates post-infarction remodeling which is associated with its beneficial effects on mitochondria.
Copyright © 2012 S. Karger AG, Basel.
Figures








Similar articles
-
Combination angiotensin converting enzyme and direct renin inhibition in heart failure following experimental myocardial infarction.Cardiovasc Ther. 2013 Apr;31(2):84-91. doi: 10.1111/j.1755-5922.2011.00292.x. Epub 2011 Jul 4. Cardiovasc Ther. 2013. PMID: 21884026
-
Divergent Effects of Cyclophilin-D Inhibition on the Female Rat Heart: Acute Versus Chronic Post-Myocardial Infarction.Cell Physiol Biochem. 2018;50(1):288-303. doi: 10.1159/000494006. Epub 2018 Oct 3. Cell Physiol Biochem. 2018. PMID: 30282073 Free PMC article.
-
Left ventricular systolic and diastolic function, remodelling, and clinical outcomes among patients with diabetes following myocardial infarction and the influence of direct renin inhibition with aliskiren.Eur J Heart Fail. 2012 Feb;14(2):185-92. doi: 10.1093/eurjhf/hfr125. Epub 2011 Sep 29. Eur J Heart Fail. 2012. PMID: 21965526 Clinical Trial.
-
[Direct renin inhibitor aliskiren in the treatment of cardiovascular and renal diseases].Vnitr Lek. 2010 Feb;56(2):120-6. Vnitr Lek. 2010. PMID: 20329582 Review. Czech.
-
[Does the rennin inhibitor aliskiren offer promising novel opportunities in the treatment of cardiovascular diseases?].Vnitr Lek. 2007 Apr;53(4):364-70. Vnitr Lek. 2007. PMID: 17578167 Review. Czech.
Cited by
-
The Role of Adenine Nucleotide Translocase in the Assembly of Respiratory Supercomplexes in Cardiac Cells.Cells. 2019 Oct 13;8(10):1247. doi: 10.3390/cells8101247. Cells. 2019. PMID: 31614941 Free PMC article.
-
Pivotal Importance of STAT3 in Protecting the Heart from Acute and Chronic Stress: New Advancement and Unresolved Issues.Front Cardiovasc Med. 2015 Nov 30;2:36. doi: 10.3389/fcvm.2015.00036. eCollection 2015. Front Cardiovasc Med. 2015. PMID: 26664907 Free PMC article. Review.
-
3-Bromo-4,5-Dihydroxybenzaldehyde Protects Against Myocardial Ischemia and Reperfusion Injury Through the Akt-PGC1α-Sirt3 Pathway.Front Pharmacol. 2018 Jul 10;9:722. doi: 10.3389/fphar.2018.00722. eCollection 2018. Front Pharmacol. 2018. PMID: 30042676 Free PMC article.
-
Cyclophilin D, Somehow a Master Regulator of Mitochondrial Function.Biomolecules. 2018 Dec 14;8(4):176. doi: 10.3390/biom8040176. Biomolecules. 2018. PMID: 30558250 Free PMC article. Review.
-
SIRT3: A New Regulator of Cardiovascular Diseases.Oxid Med Cell Longev. 2018 Feb 13;2018:7293861. doi: 10.1155/2018/7293861. eCollection 2018. Oxid Med Cell Longev. 2018. PMID: 29643974 Free PMC article. Review.
References
-
- Wollert KC, Drexler H. The renin-angiotensin system and experimental heart failure. Cardiovasc Res. 1999;43:838–849. - PubMed
-
- Dorn GW. Novel pharmacotherapies to abrogate postinfarction ventricular remodeling. Nat Rev Cardiol. (2nd) 2009;6:283–291. - PubMed
-
- Schieffer B, Wirger A, Meybrunn M, Seitz S, Holtz J, Riede UN, Drexler H. Comparative effects of chronic angiotensin-converting enzyme inhibition and angiotensin ii type 1 receptor blockade on cardiac remodeling after myocardial infarction in the rat. Circulation. 1994;89:2273–2282. - PubMed
-
- Wollert KC, Studer R, von Bulow B, Drexler H. Survival after myocardial infarction in the rat. Role of tissue angiotensin-converting enzyme inhibition. Circulation. 1994;90:2457–2467. - PubMed
-
- Westermann D, Riad A, Lettau O, Roks A, Savvatis K, Becher PM, Escher F, Jan Danser AH, Schultheiss HP, Tschope C. Renin inhibition improves cardiac function and remodeling after myocardial infarction independent of blood pressure. Hypertension. 2008;52:1068–1075. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous